Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Ovid Therapeutics Announces Pricing Of 30 Million Of Securities In Concurrent Public Offerings Of Common And Preferred Stock is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
In addition, Verve has granted the underwriters a 30-day option to purchase up to 1,875,000 additional shares of its common stock at the public ... securities laws. This press release shall ... Read More
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
In addition, TScan has granted the underwriters a 30-day option to purchase up to an additional 3,157,500 shares of its voting common stock at the public ... This press release shall not ... Read More
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
In addition, the Company announced the pricing of a concurrent private placement of pre-funded warrants to purchase 3,636,364 shares of its common stock ... Securities Act in a transaction not ... Read More
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
SAN DIEGO, Feb. 28, 2024 /PRNewswire/ -- Viking Therapeutics ... today announced the pricing of its underwritten public offering of 6,471,000 shares of its common stock at a price to the ... Read More
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
Nurix has granted the underwriters a 30-day option to purchase up to an additional 1,750,000 shares of common stock in connection with the public offering ... This press release shall not ... Read More
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
SEATTLE, WA / ACCESSWIRE / April 11, 2024 / Aptevo Therapeutics ... today announced the pricing of a public offering of (i) 3,400,000 shares of its common stock or pre-funded warrants in lieu ... Read More
PainReform Announces Pricing of $4 Million Public Offering
This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state ... Read More
Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering
The combined offering price of each share of common stock ... This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there ... Read More
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
March 28, 2024--(BUSINESS WIRE)--Stoke Therapeutics ... today announced the pricing of its upsized underwritten public offering of 5,555,557 shares of its common stock at a price to the public ... Read More
Nurix Therapeutics Announces Pricing Of Upsized $175.0 Million Public Offering
(MENAFN- GlobeNewsWire - Nasdaq) SAN FRANCISCO, April 11, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced the pricing of its upsized underwritten public offering ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus